Key result
Frailty in pituitary surgery links to higher medical complications and mortality without worsening surgical outcomes.
Why the study?
The effect of frailty on surgical success and complication rates in patients undergoing transsphenoidal pituitary surgery is unclear.
Does frailty increase perioperative complications and mortality in patients undergoing pituitary surgery?
Systematic Review (n=124,989)
Does frailty increase perioperative complications and mortality in patients undergoing pituitary surgery?
Frailty is an important indicator of perioperative risk in pituitary surgery, predicting medical complications and mortality without affecting surgical success.
Supports preoperative frailty screening to anticipate medical risks in pituitary surgery; extends observational evidence without guiding interventions.
BACKGROUND: Frailty is a state of physiological vulnerability rendering patients susceptible to adverse perioperative outcomes after neurosurgery. The effect of frailty on surgical success and complication rates in patients undergoing transsphenoidal pituitary surgery is unclear. METHODS: A systematic review of the literature was performed in accordance with the PRISMA statement. Studies that utilised validated metrics to report the effect of frailty on pituitary surgery were included. RESULTS: A total of 13 studies were included, comprising 124,989 patients. Frailty was exclusively assessed with cumulative deficit metrics, however there was significant heterogeneity in patient population, frailty definitions and assessment, and outcomes. Frail patients undergoing transsphenoidal surgery experienced higher rates of medical complications, resulting in longer hospital stays, greater hospitalisation costs, higher rates of unplanned readmission, more discharges to a destination other than home, and increased mortality. These outcomes directly correlated with increasing degrees of frailty. Surgical outcomes were not affected by frailty, with similar rates of biochemical remission, visual recovery, and improvement in quality of life. CONCLUSION: Frailty is seen in a minority of patients undergoing pituitary surgery, but is an important indicator of perioperative risk. Frailty assessment should not be used as a reason to withhold surgery, but rather to predict and mitigate perioperative complications to improve outcomes in pituitary surgery.
No takes yet. Share an insight, caveat, or question.
Castle‐Kirszbaum et al. (2025) conducted a systematic review in Pituitary and sellar region pathology (n=124,989). Frailty vs. Non-frail was evaluated on Perioperative outcomes (medical complications, length of stay, mortality, non-home discharge). Frailty in patients undergoing pituitary surgery is associated with higher rates of medical complications, longer hospital stays, and increased mortality, but does not negatively affect surgical outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: